Loading company…
Shanghai-based biopharmaceutical company developing novel anti-cancer drugs, founded in 2014.
Shanghai Kechow Pharma, Inc. is a biopharmaceutical company founded in 2014 in Shanghai, China, that researches and develops novel drugs for cancer. Its products include the anti-cancer drug HL085, the targeted drug Tuolameitini and the HL-003 chemoradiotherapy protective agent. Founder, chairman and CEO Dr. Hongqi Tian has more than 20 years of experience in new drug development. In February 2024 the company closed series D+ funding from Wanlian Tianze and Wanlian Securities.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in